# Dianthus Therapeutics, Inc.: Form 8-K, filed Mar 26, 2026

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2026-03-26
- Accepted by EDGAR: Mar 26, 2026, 08:00 ET
- Period: 2026-03-26
- Accession: 0001690585-26-000010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000169058526000010/dnth-20260326.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000169058526000010/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000169058526000010/dnth-20260326.htm

Filed Mar 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001690585-26-000010. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
